专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明授权

US06705911B2 Method for fabricating flat fluorescent lamp 失效
标题翻译：平面荧光灯的制造方法
公开(公告)号：US06705911B2
公开(公告)日：2004-03-16
申请号：US10082076
申请日：2002-02-26
申请人： Yoon-jung Lee , Seoung-jae Im
发明人： Yoon-jung Lee , Seoung-jae Im
IPC分类号： H01J902
CPC分类号： H01J9/223 , C09K11/02 , C09K11/08
摘要： A method for manufacturing a flat fluorescent lamp is provided. The method involves: preparing a transparent front plate; preparing a transparent back plate facing the front plate, the back plate having a plurality of discharging electrodes thereon and a dielectric layer covering the discharging electrodes; forming a plurality of spacers between the front plate and the back plate to keep a separation gap therebetween; and forming a fluorescent layer by spraying phosphor slurry on one surface of at least one of the front plate and the back plate.
摘要翻译：提供一种制造平面荧光灯的方法。该方法涉及：制备透明前板; 制备面向前板的透明背板，背板上具有多个放电电极和覆盖放电电极的电介质层; 在前板和后板之间形成多个间隔件，以保持它们之间的间隔; 以及通过在前板和后板中的至少一个的一个表面上喷洒磷光体浆料形成荧光层。

2. 发明授权

US09096571B2 Picolinamide and pyrimidine-4-carboxamide compounds, process for preparing and pharmaceutical composition comprising the same 有权
标题翻译：吡啶酰胺和嘧啶-4-甲酰胺化合物，其制备方法和包含其的药物组合物
公开(公告)号：US09096571B2
公开(公告)日：2015-08-04
申请号：US13696400
申请日：2011-05-04
申请人： Je Ho Ryu , Shin Ae Kim , Keun Ho Ryu , Jae Sun Kim , Nam Ho Kim , Hye Young Han , Yong Hyuk Kim , Won-No Youn , Yoon-Jung Lee , Hyun Joo Son , Bong-Yong Lee , Sung Hoon Park , Ju Young Lee , Hyun Jung Lee , Hoe Chul Jung , Young Ah Shin , Jung A Lee , Bo Ram Lee , Joon Ho Sa
发明人： Je Ho Ryu , Shin Ae Kim , Keun Ho Ryu , Jae Sun Kim , Nam Ho Kim , Hye Young Han , Yong Hyuk Kim , Won-No Youn , Yoon-Jung Lee , Hyun Joo Son , Bong-Yong Lee , Sung Hoon Park , Ju Young Lee , Hyun Jung Lee , Hoe Chul Jung , Young Ah Shin , Jung A Lee , Bo Ram Lee , Joon Ho Sa
IPC分类号： A61K31/47 , A61K31/55 , A61K31/445 , A61K31/497 , C07D401/04 , C07D401/14 , C07D403/04 , C07D403/14 , C07D405/14 , C07D213/81 , C07D401/06 , C07D401/12 , C07D405/12 , C07D239/557
CPC分类号： C07D401/04 , C07D213/81 , C07D239/557 , C07D401/06 , C07D401/12 , C07D401/14 , C07D403/04 , C07D403/14 , C07D405/12 , C07D405/14
摘要： Provided are picolinamide and pyrimidine-4-carboxamide compounds, a method for preparing the same, a pharmaceutical composition containing the same, and a medical use using the compound as an agent for preventing, regulating, and treating diseases related to regulation of glucocorticoids by using selective inhibitory activity of the compound for an 11β-HSD1 enzyme. The picolinamide and pyrimidine-4-carboxamide compounds of the present invention are selective inhibitors of human-derived 11β-HSD1 enzymes, and are useful in an agent for preventing, regulating, and treating diseases related to glucocorticoid regulation in which human-derived 11β-HSD1 enzymes are involved, for example, metabolic syndromes such as, type 1 and type 2 diabetes, diabetes later complications, latent autoimmune diabetes adult (LADA), insulin tolerance syndromes, obesity, impaired glucose tolerance (IGT), impaired fasting glucose (IFG), damaged glucose tolerance, dyslipidemia, atherosclerosis, hypertension, etc.
摘要翻译：提供了吡啶酰胺和嘧啶-4-甲酰胺化合物，其制备方法，含有该组合物的药物组合物，以及使用该化合物作为预防，调节和治疗与糖皮质激素调节有关的疾病的药物的用途该化合物对于11-bgr-HSD1酶的选择性抑制活性。本发明的吡啶酰胺和嘧啶-4-甲酰胺化合物是人源性11β-HSD1酶的选择性抑制剂，可用于预防，调节和治疗糖皮质激素调节相关疾病的药剂，其中人源性11β- ; -HSD1酶涉及例如代谢综合征，如1型和2型糖尿病，糖尿病后期并发症，潜伏性自身免疫性糖尿病成人（LADA），胰岛素耐受综合征，肥胖，葡萄糖耐量异常（IGT），空腹血糖受损（IFG），葡萄糖耐量受损，血脂异常，动脉粥样硬化，高血压等。

3. 发明申请

US20100099773A1 INCLUSION COMPLEX OF SIBUTRAMINE AND BETA-CYCLODEXTRIN 审中-公开
标题翻译：包含SIBUTRAMINE和BETA-CYCLODEXTRIN的复合物
公开(公告)号：US20100099773A1
公开(公告)日：2010-04-22
申请号：US12444080
申请日：2007-11-22
申请人： Jae-Sun Kim , Nam Ho Kim , Jin Young Lee , Nam Kyu Lee , Joon Gyo Oh , Yong Youn Hwang , Dong-Chul Shin , Yoon-Jung Lee , Key An Um , Sun Ho Kim , Jin-Heung Sung
发明人： Jae-Sun Kim , Nam Ho Kim , Jin Young Lee , Nam Kyu Lee , Joon Gyo Oh , Yong Youn Hwang , Dong-Chul Shin , Yoon-Jung Lee , Key An Um , Sun Ho Kim , Jin-Heung Sung
IPC分类号： A61K31/135 , A61P25/00
CPC分类号： A61K31/135 , A61K47/6951 , B82Y5/00 , C08B37/0015
摘要： The present invention relates to a sibutramine-containing inclusion complex having superior storage stability, and particularly to a pharmaceutically stable inclusion complex suitable for the drug formulation, which prepared by reacting a sibutramine (N,N-dimethyl-1-[1-(4-chlorophenyl)-cyclobutyl]-3-methylbutylamine) of Formula 1 and beta-cyclodextrin in a predetermined ratio, its preparation method and a pharmaceutical composition comprising the same.
摘要翻译：本发明涉及具有优异储存稳定性的西布曲明含量复合物，特别涉及适用于药物制剂的药学上稳定的包合络合物，其通过使西布曲明（N，N-二甲基-1- [1-（4 - 氯苯基） - 环丁基] -3-甲基丁胺）和β-环糊精，其制备方法和包含其的药物组合物。

4. 发明申请

US20090163574A1 Stable Pharmaceutical Composition Containing Docetaxel and a Method of Manufacturing the Same 失效
标题翻译：含有多西紫杉醇的稳定药物组合物及其制造方法
公开(公告)号：US20090163574A1
公开(公告)日：2009-06-25
申请号：US12301700
申请日：2007-05-22
申请人： Nam Ho Kim , Jin Young Lee , Jae-Sun Kim , Nam Kyu Lee , Woo Jae Jang , Joon Gyo Oh , Yoon-Jung Lee , Woong Sik Kim , Jin-Heung Sung , Key An Um
发明人： Nam Ho Kim , Jin Young Lee , Jae-Sun Kim , Nam Kyu Lee , Woo Jae Jang , Joon Gyo Oh , Yoon-Jung Lee , Woong Sik Kim , Jin-Heung Sung , Key An Um
IPC分类号： A61K31/337
CPC分类号： A61K9/0019 , A61K9/19 , A61K31/337 , A61K31/724 , A61K47/10 , A61K47/32 , A61K47/38 , A61K47/40 , A61K2300/00
摘要： The present invention relates to a stable pharmaceutical composition for injection containing docetaxel and a method of preparing the same. More particularly, the present invention relates to a pharmaceutical composition for injection containing docetaxel having better storage stability than conventional medications, which is prepared by dissolving docetaxel, a water-insoluble compound, in distilled water after mixing it with cyclodextrin (CD) and a water-soluble polymer such as hydroxypropyl methylcellulose (HPMC), polyethylene glycol (PEG) or polyvinylpyrrolidone (PVP) and lyophilizing the mixture, and a method of preparing the same.
摘要翻译：本发明涉及含有多西紫杉醇的稳定的注射用药物组合物及其制备方法。更具体地说，本发明涉及含有多西紫杉醇的药物组合物，其具有比常规药物更好的储存稳定性，其通过将多巴紫杉醇，水不溶性化合物与环糊精（CD）和水混合后在蒸馏水中溶解而制备可溶性聚合物如羟丙基甲基纤维素（HPMC），聚乙二醇（PEG）或聚乙烯吡咯烷酮（PVP），并将混合物冷冻干燥及其制备方法。

5. 发明授权

US06885151B2 Flat lamp with horizontal facing electrodes 失效
标题翻译：带水平面电极的扁平灯
公开(公告)号：US06885151B2
公开(公告)日：2005-04-26
申请号：US10347456
申请日：2003-01-21
申请人： Gi-young Kim , Hyoung-bin Park , Seoung-jae Im , Ji-hyun Hong , Yoon-jung Lee
发明人： Gi-young Kim , Hyoung-bin Park , Seoung-jae Im , Ji-hyun Hong , Yoon-jung Lee
IPC分类号： H01J65/00 , H01J61/30 , H01J65/04 , H01J17/04 , H01J1/62
CPC分类号： H01J65/046
摘要： A flat lamp with horizontal facing electrodes is provided, in which a front substrate and a rear substrate are spaced such as to face each other. Walls between the front and rear substrates form a discharging space filled with a discharge gas. A plurality of front electrodes and a plurality of rear electrodes are provided on facing surfaces of the front and rear substrates, respectively. The front and rear electrodes, formed in strips, are arranged in such a way that the front electrodes alternate with the rear electrodes. Accordingly, the discharging distance between front and rear electrodes is lengthened, and many fine discharging operations occur between tip electrodes extending from the lateral sides of the electrode strips and flat portions of corresponding electrode strips. Therefore, a current concentration is prevented, thereby achieving uniform discharging. Also, brightness of the flat lamp increases.
摘要翻译：提供具有水平面对电极的扁平灯，其中前基板和后基板彼此间隔开。前后基板之间的壁形成填充有放电气体的放电空间。分别在前基板和后基板的相对表面上设置有多个前电极和多个后电极。形成为条状的前电极和后电极被布置成使得前电极与后电极交替。因此，前后电极之间的放电距离延长，并且在从电极条的侧面延伸的尖端电极和对应的电极条的平坦部分之间发生许多精细的放电操作。因此，防止电流集中，从而实现均匀的放电。此外，平板灯的亮度增加。

6. 发明申请

US20130210811A1 PICOLINAMIDE AND PYRIMIDINE-4-CARBOXAMIDE COMPOUNDS, PROCESS FOR PREPARING AND PHAMACEUTICAL COMPOSITION COMPRISING THE SAME 有权
标题翻译：吡啶酰胺和嘧啶-4-羧酰胺化合物，其制备方法和包含其的药物组合物
公开(公告)号：US20130210811A1
公开(公告)日：2013-08-15
申请号：US13696400
申请日：2011-05-04
申请人： Je Ho Ryu , Shin Ae Kim , Keun Ho Ryu , Jae Sun Kim , Nam Ho Kim , Hye Young Han , Yong Hyuk Kim , Won-No Youn , Yoon-Jung Lee , Hyun Joo Son , Bong-Yong Lee , Sung Hoon Park , Ju Young Lee , Hyun Jung Lee , Hoe Chul Jung , Young Ah Shin , Jung A Lee , Bo Ram Lee , Joon Ho Sa
发明人： Je Ho Ryu , Shin Ae Kim , Keun Ho Ryu , Jae Sun Kim , Nam Ho Kim , Hye Young Han , Yong Hyuk Kim , Won-No Youn , Yoon-Jung Lee , Hyun Joo Son , Bong-Yong Lee , Sung Hoon Park , Ju Young Lee , Hyun Jung Lee , Hoe Chul Jung , Young Ah Shin , Jung A Lee , Bo Ram Lee , Joon Ho Sa
IPC分类号： C07D401/04 , C07D403/14 , C07D403/04 , C07D401/14 , C07D405/14
CPC分类号： C07D401/04 , C07D213/81 , C07D239/557 , C07D401/06 , C07D401/12 , C07D401/14 , C07D403/04 , C07D403/14 , C07D405/12 , C07D405/14
摘要： Provided are picolinamide and pyrimidine-4-carboxamide compounds, a method for preparing the same, a pharmaceutical composition containing the same, and a medical use using the compound as an agent for preventing, regulating, and treating diseases related to regulation of glucocorticoids by using selective inhibitory activity of the compound for an 11β-HSD1 enzyme. The picolinamide and pyrimidine-4-carboxamide compounds of the present invention are selective inhibitors of human-derived 11β-HSD1 enzymes, and are useful in an agent for preventing, regulating, and treating diseases related to glucocorticoid regulation in which human-derived 11β-HSD1 enzymes are involved, for example, metabolic syndromes such as, type 1 and type 2 diabetes, diabetes later complications, latent autoimmune diabetes adult (LADA), insulin tolerance syndromes, obesity, impaired glucose tolerance (IGT), impaired fasting glucose (IFG), damaged glucose tolerance, dyslipidemia, atherosclerosis, hypertension, etc.
摘要翻译：提供了吡啶酰胺和嘧啶-4-甲酰胺化合物，其制备方法，含有该组合物的药物组合物，以及使用该化合物作为预防，调节和治疗与糖皮质激素调节有关的疾病的药物的用途化合物对11beta-HSD1酶的选择性抑制活性。本发明的吡啶酰胺和嘧啶-4-甲酰胺化合物是人源性11beta-HSD1酶的选择性抑制剂，可用于预防，调节和治疗与糖皮质激素调节相关的疾病的药剂，其中人源性11β- 涉及HSD1酶，例如代谢综合征，如1型和2型糖尿病，糖尿病后期并发症，潜伏性自身免疫性糖尿病成年（LADA），胰岛素耐受综合征，肥胖症，葡萄糖耐量异常（IGT），空腹血糖受损（IFG ），葡萄糖耐量受损，血脂异常，动脉粥样硬化，高血压等。

7. 发明授权

US06628088B2 Plasma display panel using excimer gas 失效
公开(公告)号：US06628088B2
公开(公告)日：2003-09-30
申请号：US09876083
申请日：2001-06-08
申请人： Young-mo Kim , Hidekazu Hatanaka , Won-tae Lee , Seoung-jae Im , Yoon-jung Lee
发明人： Young-mo Kim , Hidekazu Hatanaka , Won-tae Lee , Seoung-jae Im , Yoon-jung Lee
IPC分类号： G09G310
CPC分类号： H01J11/10 , H01J11/50
摘要： A plasma display panel using excimer gas is provided. Mixed excimer gases containing xenon (Xe) used to form excimer gas and iodine (I) as a halogen, are injected into the plasma display panel to be used as discharge gases. At least one selected from helium (He), neon (Ne), argon (Ar) and krypton (Kr) can be used as a buffering gas for the discharging gases. At least some of ultraviolet rays originate from the excimer gases and at least some of iodine is supplied from I2. The partial pressure of molecular iodine is less than or equal to a saturated vapor pressure, at operating temperature of the plasma display panel, at room temperature and at 0° C., respectively. The partial pressure of iodine inside the plasma display panel is in the range of 0.01 to 50% based on the total pressure of excimer gases.

8. 发明授权

US08791152B2 Stable pharmaceutical composition containing docetaxel and a method of manufacturing the same 失效
标题翻译：含有多西紫杉醇的稳定的药物组合物及其制造方法
公开(公告)号：US08791152B2
公开(公告)日：2014-07-29
申请号：US12301700
申请日：2007-05-22
申请人： Nam Ho Kim , Jin Young Lee , Jae-Sun Kim , Nam Kyu Lee , Woo Jae Jang , Joon Gyo Oh , Yoon-Jung Lee , Woong Sik Kim , Jin-Heung Sung , Key An Um
发明人： Nam Ho Kim , Jin Young Lee , Jae-Sun Kim , Nam Kyu Lee , Woo Jae Jang , Joon Gyo Oh , Yoon-Jung Lee , Woong Sik Kim , Jin-Heung Sung , Key An Um
IPC分类号： A61K31/335
CPC分类号： A61K9/0019 , A61K9/19 , A61K31/337 , A61K31/724 , A61K47/10 , A61K47/32 , A61K47/38 , A61K47/40 , A61K2300/00
摘要： The present invention relates to a stable pharmaceutical composition for injection containing docetaxel and a method of preparing the same. More particularly, the present invention relates to a pharmaceutical composition for injection containing docetaxel having better storage stability than conventional medications, which is prepared by dissolving docetaxel, a water-insoluble compound, in distilled water after mixing it with cyclodextrin (CD) and a water-soluble polymer such as hydroxypropyl methylcellulose (HPMC), polyethylene glycol (PEG) or polyvinylpyrrolidone (PVP) and lyophilizing the mixture, and a method of preparing the same.
摘要翻译：本发明涉及含有多西紫杉醇的稳定的注射用药物组合物及其制备方法。更具体地说，本发明涉及含有多西紫杉醇的药物组合物，其具有比常规药物更好的储存稳定性，其通过将多巴紫杉醇，水不溶性化合物与环糊精（CD）和水混合后在蒸馏水中溶解而制备可溶性聚合物如羟丙基甲基纤维素（HPMC），聚乙二醇（PEG）或聚乙烯吡咯烷酮（PVP），并将混合物冷冻干燥及其制备方法。

9. 发明申请

US20100069632A1 SALTS OF PYRROLOPYRIMIDINONE DERIVATIVES AND PROCESS FOR PREPARING THE SAME 审中-公开
标题翻译：吡咯烷酮衍生物的制备方法及其制备方法
公开(公告)号：US20100069632A1
公开(公告)日：2010-03-18
申请号：US12307144
申请日：2007-07-03
申请人： Nam Ho Kim , Jin-Young Lee , Jae-Sun Kim , Nam Kyu Lee , Woo Jae Jang , Joo Gyo Oh , Yoon-Jung Lee , Won-No Youn , Jin-Heung Sung , Key An Um
发明人： Nam Ho Kim , Jin-Young Lee , Jae-Sun Kim , Nam Kyu Lee , Woo Jae Jang , Joo Gyo Oh , Yoon-Jung Lee , Won-No Youn , Jin-Heung Sung , Key An Um
IPC分类号： C07D487/04
CPC分类号： C07D487/04
摘要： The present invention relates to salts of a pyrrolopyrimidinone derivative having superior PDE-5 inhibition activity and a process for preparing the same. More particularly, the present invention relates to a crystalline acid addition salt prepared by reacting a pyrrolopyrimidinone derivative with an acid selected from gentisic acid, maleic acid, citric acid, fumaric acid and tartaric acid. With no hygroscopic property and superior long-term storage stability, photostability and thermal stability, the salts of the pyrrolopyrimidinone derivative are appropriate to be prepared into medications and, with superior PDE-5 inhibition activity, are useful for the treatment and prevention of erectile dysfunction, pulmonary arterial hypertension, chronic obstructive pulmonary disease, benign prostatic hypertrophy and lower urinary tract diseases.
摘要翻译：本发明涉及具有优异的PDE-5抑制活性的吡咯并嘧啶酮衍生物的盐及其制备方法。更具体地，本发明涉及通过使吡咯并嘧啶酮衍生物与选自龙胆酸，马来酸，柠檬酸，富马酸和酒石酸的酸反应制备的结晶酸加成盐。无吸湿性和优异的长期储存稳定性，光稳定性和热稳定性，吡咯并嘧啶酮衍生物的盐适于制备成药物，并且具有优异的PDE-5抑制活性，可用于治疗和预防勃起功能障碍肺动脉高压，慢性阻塞性肺疾病，良性前列腺肥大和下尿路疾病。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式